Overview
Don Henslee is an Urologist in Lincoln, Nebraska. Dr. Henslee is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Perirenal Abscess, Ureteroscopy, and Nephrectomy. Dr. Henslee is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE PDP
- EPO
- HMO
- PPO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5500 Pine Lake Rd, Lincoln, NE 68516
Nebraska Urology PC
David Wiltfong is an Urologist in Lincoln, Nebraska. Dr. Wiltfong is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, UPJ Obstruction, Ureteroscopy, and Vasectomy. Dr. Wiltfong is currently accepting new patients.
Nebraska Urology PC
Andrew Lepinski is an Urologist in Lincoln, Nebraska. Dr. Lepinski is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Urinary Incontinence, Familial Prostate Cancer, Prostate Cancer, Ureteroscopy, and Nephrectomy. Dr. Lepinski is currently accepting new patients.
Nebraska Urology PC
Lance Wiebusch is an Urologist in Lincoln, Nebraska. Dr. Wiebusch is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Urinary Incontinence, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Wiebusch is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- BoilsDr. Henslee isDistinguished. Learn about Boils.
- Enlarged Prostate (BPH)Dr. Henslee isDistinguished. Learn about Enlarged Prostate (BPH).
- Familial Prostate CancerDr. Henslee isDistinguished. Learn about Familial Prostate Cancer.
- Perirenal AbscessDr. Henslee isDistinguished. Learn about Perirenal Abscess.
- Prostate CancerDr. Henslee isDistinguished. Learn about Prostate Cancer.
- Urinary IncontinenceDr. Henslee isDistinguished. Learn about Urinary Incontinence.
- Advanced
- Bladder CancerDr. Henslee isAdvanced. Learn about Bladder Cancer.
- CarbuncleDr. Henslee isAdvanced. Learn about Carbuncle.
- Eunuchoidism Familial Hypogonadotropic
- FolliculitisDr. Henslee isAdvanced. Learn about Folliculitis.
- Kidney StonesDr. Henslee isAdvanced. Learn about Kidney Stones.
- MalakoplakiaDr. Henslee isAdvanced. Learn about Malakoplakia.
- Experienced
- BalanitisDr. Henslee isExperienced. Learn about Balanitis.
- Bilateral HydronephrosisDr. Henslee isExperienced. Learn about Bilateral Hydronephrosis.
- Bladder Outlet ObstructionDr. Henslee isExperienced. Learn about Bladder Outlet Obstruction.
- Bladder StonesDr. Henslee isExperienced. Learn about Bladder Stones.
- Chromophobe Renal Cell CarcinomaDr. Henslee isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Henslee isExperienced. Learn about Clear Cell Sarcoma.